Use of Generative AI is expected to grow significantly in chemistry and biology for molecular generation and drug discovery. Generative AI looks promising for the pharma industry, given the opportunity to reduce costs and time in taking new drugs to market. Dedicated services like BioNemo from NVIDIA will accelerate the journey to AI- powered drug discovery, offering tools to quickly train, customize, deploy, and perform inference on state-of-the-art generative and predictive biomolecular AI models at-scale. Explore how the intersection of generative AI with biology and healthcare is driving breakthrough innovations. Predictions Predictions for the coming year are: • OpenAI is expected to release GPT-4, which is predicted to significantly surpass ChatGPT in performance and surprise users with its capabilities. • GPT-4 is anticipated to be capable of generating entire books in any desired style, complete with unique charts and illustrations. • Many major technology companies will release competitors to GPT-4, and we will see the continued evolution of open-source projects such as the highly anticipated release of Stable Diffusion 3. • AI is predicted to become an integral component of every major technology product in the near future. • The coming year may also see the emergence of new startups that reimagine existing businesses in ways that are presently unforeseeable. Predictions for the next 2-5 years are: • AI will become a ubiquitous part of every business, even those that operate offline. • Employees who receive proper training in AI may become many orders of magnitude more productive than employees today. • AI technology will provide the capability to learn anything and create virtually anything in the digital world, opening up a whole new world of possibilities for creative entrepreneurs. • A new kind of startup with only 1-10 people will emerge, capable of performing like companies with 1,000 employees thanks to the power of AI. Gen AI: Revolutionizing the Way Enterprises Work 30